Healthcare is slowly moving from treating illness after it appears to identifying risks much earlier. Vytalyou, a Mumbai-based preventive healthcare and longevity startup, is building its business around this idea.

The company has raised Rs. 9 crore in a pre-Series A funding round from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries. The round values Vytalyou at approximately Rs. 33 crore, according to reports.

What Vytalyou does

Vytalyou was founded in 2025 by molecular oncologist Dr. Chirantan Bose and radiologist Dr. Preetesh Bhandari.

The startup operates doctor-led longevity clinics that combine health assessments, predictive diagnostics and personalized preventive programmes.

The company’s approach is different from a regular health check-up. A standard check-up generally provides a set of test results. Vytalyou says its predictive longevity evaluation is designed to build a broader picture of a person’s health, biological ageing and possible future risks.

Doctors then review the findings and create a medically supervised plan. Depending on the individual’s needs, this may include lifestyle advice, additional tests, follow-up monitoring and selected therapies related to cellular and mitochondrial health.

The company’s services include pathology, radiology, cardiac and respiratory assessments, body composition analysis, genetic testing, cancer screening, gut microbiome evaluation and personalized intravenous therapies. These services are presented as part of a wider preventive healthcare programme, not as a replacement for emergency or conventional medical treatment.

How the Rs. 9 crore funding will be used

As per Biospectrum, the immediate purpose of the funding is to expand Vytalyou’s clinic network in Mumbai. The company plans to add two more centres by the end of the year, taking its Mumbai presence to three locations, including its existing Powai facility.

Vytalyou has also set a longer-term target of reaching 10 locations across India. The fresh capital may support clinic setup, medical equipment, hiring doctors and specialists, technology development, patient acquisition and operational systems.

For example, a new centre could allow more people to access detailed screening and doctor-led health planning without travelling across the city. As the network grows, the company may also be able to standardize its testing and follow-up processes.

Why preventive healthcare is gaining attention

Lifestyle-related conditions such as diabetes, heart disease and obesity are creating demand for earlier risk detection and regular monitoring. Many people are also becoming more interested in healthy ageing, nutrition, fitness and long-term wellness.

However, the longevity sector needs careful medical oversight. Predictive tools and wellness therapies should support qualified doctors, and customers should understand that no health programme can guarantee a longer life or prevent every disease.

Competition and market position

Vytalyou operates in an emerging space that includes preventive healthcare, longevity clinics and health diagnostics. Startups such as Decode Age, Biopeak, Cent and Elevate Now are working in related areas, though their products and business models differ.

Vytalyou’s distinction is its clinic-based model, where testing, medical review and personalized programmes are offered together. Its challenge will be to build trust, show measurable outcomes and maintain consistent medical standards across every location.

Conclusion with key takeaways

Vytalyou’s Rs. 9 crore pre-Series A round will help it expand its Mumbai clinic network and move closer to its wider India growth plan. The startup aims to make preventive and longevity-focused healthcare more structured and doctor-led.

Its success will depend on responsible use of health data, qualified medical supervision and evidence-backed services. Funding can help the company grow, but credibility and patient outcomes will ultimately decide how far its model can travel.

Image